DeePathology.ai develops a decision-support system for digital pathology using artificial-intelligence (AI) technology.

The company's proprietary AI technology allows it to implement AI solutions for the digital pathology market quickly and accurately for problems such as helicobacter pylori detection in gastric biopsies, plaque detection in brain biopsies, and lymphocyte detection.DeePathology has cell-detection and tissue-segmentation solutions that allow pathologists and researchers to quickly and easily develop their own AI-based solutions in their own lab without becoming AI experts.DeePathlogy solutions are already in use in various locations in Europe where they are integrated into the workflow and routines of pathologists.